Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 22 December, 2009 and appeared in  Issue 501

Test Your Knowledge #501: Which of the following statements best describes the rationale for aggressive therapy...

Which of the following statements best describes the rationale for aggressive therapy, which targets multiple pathophysiologic defects of Type 2 diabetes?

Advertisement

A. Targeting multiple pathophysiologic defects of Type 2 diabetes is most likely to reduce cardiovascular risk.

B. Targeting multiple pathophysiologic defects of Type 2 diabetes is most likely to improve glycemic control, thereby improving cardiovascular risk and possibly beta cell function.

C. Patients are more likely to adhere to aggressive therapy for Type 2 diabetes.

D. Aggressive therapy for Type 2 diabetes is most likely to result in substantial weight loss.

For the correct answer, please click here.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 22 December, 2009 and appeared in  Issue 501

Past five issues: Issue 677 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 | Diabetes Clinical Mastery Series Issue 135 | Issue 675 |

2013 Most Popular Articles:

AACE Releases New Comprehensive Diabetes Management Algorithm
Posted April 25, 2013
AACE - New Diabetes Guidelines Based on Tailored Approach
Posted May 09, 2013
Discovery Raises Hope for Type 1 Diabetes Reversal
Posted May 03, 2013
AACE: Ralph A. DeFronzo, MD -- Diabetes Prevention Supports More Aggressive and Earlier Intervention
Posted May 09, 2013
Intermittent Fasting May Improve Diabetes and Reduce Cardiovascular Risk
Posted May 03, 2013
AACE – New Test Efficiently Detects Diabetic Neuropathy
Posted May 09, 2013
AACE: CAD Risk for Pre-Diabetes Similar to Diabetes
Posted May 09, 2013
Low-Glycemic Diet Seen to Reverse Diastolic Dysfunction of Diabetes
Posted May 03, 2013
New Pill in the Works for Type 1 Patients
Posted April 19, 2013
New Updated Hypoglycemia Classifications
Posted April 19, 2013

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control



Search Articles On Diabetes In Control